Skip to main content
Home
language-selector-globe Slovenia | en
Choose Location
language-selector-globe Slovenia |
EnglishSlovenian
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Latin America | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Israel | he
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Slovenia | sl
Slovenia | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Novartis | en
Sandoz | en
Egypt | en
South Africa | en
Turkey | tr
language-selector-globe si
Choose Location
language-selector-globeSlovenia
EnglishSlovenian
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latin America | es
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
Slovenia | sl
Slovenia | en
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • About 
      • Novartis in Slovenia 
      • Country Leadership Team 
      • Strategy 
      • Diversity, Equity and Inclusion 
      • People and culture 
      • Products 
      • Contacts 
      Novartis v Sloveniji. Znanstvenica v laboratoriju About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Adverse Event Reporting 
      • Diseases 
      • Products 
      Starejša bolnica in mlajša negovalka Patients and Caregivers
    • Healthcare Professionals 
      • Healthcare professional country resource 
      • Products 
      • Pipeline 
      • Adverse Event Reporting 
      • Clinical studies 
      Starejši gospod na pregledu pri zdravniku Healthcare Professionals
    • ESG 
      • Ethics, risk and compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      • Ethical Behavior 
      • Reporting 
      Dve osebi, ki se držita za roke ESG
    • Media 
      • News Archive 
      • Media Contact 
      Moški bere časopis Media
    • Careers 
      • Careers at Novartis in Slovenia 
      • How We Work 
      • Wellbeing 
      • Diversity, Equity and Inclusion 
      • BioCamp 
      • Meet the teams 
      • Personal Growth 
      • Early Talent 
      • Awards and Recognition 
      Ženska in moški za računalnikom Careers
    • Development and production of innovative medicines 
    • BioCamp 2024 
    Znanstvenica, Novartis v Sloveniji Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area Sort descending
  • Date Posted
Job Title Site Location Division Business Functional Area Sort descending Date Posted
Director, Public Affairs Shanghai (Shanghai) China People & Organization Innovative Medicines Communications & Public Affairs 06 May 2024
Executive Director, Public Affairs LaCan Region East Hanover USA Corporate Affairs Corporate Communications & Public Affairs 09 May 2024
Public Affairs Manager (m/f/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Communications & Public Affairs 09 July 2024
Government Affairs Manager Moscow (City) Russian Fed. Corporate Affairs Innovative Medicines Communications & Public Affairs 29 July 2024
Manager, Post Production & Video Services Hyderabad (Office) India Corporate Affairs CTS Communications & Public Affairs 04 October 2024
Manager, US Channel Operations & Publishing East Hanover USA Corporate Affairs CTS Communications & Public Affairs 05 September 2024
Associate Director, R&D Portfolio and Engagement - Communications Cambridge (Massachusetts) USA Corporate Affairs CTS Communications & Public Affairs 08 October 2024
Associate Director, Finance and Strategy & Growth Activation Communications East Hanover USA Corporate Affairs CTS Communications & Public Affairs 08 October 2024
Patient Engagement Lead İstanbul Kavacık Turkey Corporate Affairs CTS Communications & Public Affairs 03 September 2024
Manager, US Policy & Issues Communications East Hanover USA Corporate Affairs CTS Communications & Public Affairs 18 September 2024
Public Affairs Manager Ankara Gimat Turkey International Innovative Medicines Communications & Public Affairs 13 September 2024
Communication & Patient Advocacy Manager (f/m/d) Vienna Austria International CTS Communications & Public Affairs 24 September 2024
EA & Program Coordinator Beijing (Beijing) China Corporate Affairs Innovative Medicines Communications & Public Affairs 03 September 2024
Sr. Spec. IT Solution Delivery INSURGENTES Mexico Operations CTS Information Technology 15 July 2024
Senior Specialist DDIT OPS Mfg Site IT Sasayama Japan Operations CTS Information Technology 22 July 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality 03 September 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality 03 September 2024
Analyst - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality 03 September 2024
Quality Manager GCP / PV Hyderabad (Office) India Development Innovative Medicines Quality 03 September 2024
Specialist Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality 03 September 2024
Specialist – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality 03 September 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality 03 September 2024
Specialist – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality 03 September 2024
Associate, QA Officer Operations Sasayama Japan Operations Innovative Medicines Quality 03 September 2024
Specialist - Product Complaints - QOP Hyderabad (Office) India Operations Innovative Medicines Quality 03 September 2024
Specialist - QA Ops - Manufacturing Mgmt Tuas South Avenue Singapore Operations Innovative Medicines Quality 03 September 2024
AS&T Specialist İstanbul Kurtköy Turkey Operations Innovative Medicines Quality 03 September 2024
Senior Specialist, QA Ops - Lifecycle Management Tuas South Avenue Singapore Operations Innovative Medicines Quality 31 May 2024
QualityTeamLeader,QA Ops-Mfg Mgt(QA SF) Tuas South Avenue Singapore Operations Innovative Medicines Quality 03 September 2024
QC Specialist I Tuas South Avenue Singapore Operations Innovative Medicines Quality 03 September 2024
QC Analyst IV - Analytical Tuas South Avenue Singapore Operations Innovative Medicines Quality 04 June 2024
eCompliance Manager Hyderabad (Office) India Operations Innovative Medicines Quality 03 September 2024
Expert GMP Auditor Mumbai (Office) India Operations Innovative Medicines Quality 03 September 2024
Senior GCP/PV Auditor Mumbai (Head Office) India Operations Innovative Medicines Quality 03 September 2024
Senior GCP/PV Auditor Mumbai (Head Office) India Operations Innovative Medicines Quality 03 September 2024
AS&T Expert - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality 03 September 2024
AS&T Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality 03 September 2024
QA Compliance Expert – Reg CMC Facilitator Hyderabad (Office) India Operations Innovative Medicines Quality 03 September 2024
Quality Compliance and Risk Manager (GCP/PV) Manager Barcelona Gran Vía Spain Development Innovative Medicines Quality 31 July 2024
Associate Director Data Ops & Analytics, RDQ Hyderabad (Office) India Development Innovative Medicines Quality 03 September 2024
Specialist - QA Ops - Manufacturing Mgmt Tuas South Avenue Singapore Operations Innovative Medicines Quality 03 September 2024
AS&T Hub Team Coordinator İstanbul Kurtköy Turkey Operations Innovative Medicines Quality 03 September 2024
Expert, QA Ops - Lifecycle Management Tuas South Avenue Singapore Operations Innovative Medicines Quality 03 September 2024
Senior QC Specialist Kundl Austria Operations Innovative Medicines Quality 09 September 2024
AS&T Specialist (m/w/d) Kundl, Tirol Kundl Austria Operations Innovative Medicines Quality 16 September 2024
Compliance & Quality System Manager Ivrea Italy Operations Innovative Medicines Quality 23 September 2024
(Senior) QA Operations Specialist Schaftenau Austria Operations Innovative Medicines Quality 26 September 2024
QC PLANNER - CDI (h/f) Huningue France Operations Innovative Medicines Quality 26 September 2024
QC Analyst II / Labortechniker (m/w/d), Schaftenau, Tirol Schaftenau Austria Operations Innovative Medicines Quality 07 October 2024
QC Analyst II. Basel (Land) Switzerland Operations Innovative Medicines Quality 03 September 2024

Pagination

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis Slovenia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • Media
  • Career
Media
  • News Archive
Our Portfolio
  • Novartis Products
  • Novartis Pipeline
Other Novartis websites
  • Global site
Footer Bottom
© 2024 Novartis d.o.o.
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for a global audience